Using Cerenia
When Patients Are Back In Business
  • Benefits to your patients
    Help ease a dog’s recovery by adding Cerenia to your perioperative protocol, to prevent vomiting and enable a quicker return to feeding.¹
  • Benefits to your practice
    A third of practice owners reported the impact of cleaning up after patients that vomit.² With Cerenia, less cleaning can mean more time for patient care, leading to greater dog owner satisfaction.³
Happier Patients
Cerenia Injectable Ralph img
  • 91% of canine patients experienced a faster return to normal feeding1
  • 88% of pet owners had a positive reaction to their pets' return to normal feeding within 24 hours4
  • 99% of dog owners said they would definitely or probably choose treatment to prevent opioid-induced vomiting in their pets3

Visit our website at www.cereniadvm.com to learn more about the first FDA-approved medication to prevent perioperative vomiting in dogs.5

IMPORTANT SAFETY INFORMATION: Use Cerenia Injectable subcutaneously for acute vomiting in dogs 2 to 4 months of age or either subcutaneously or intravenously in dogs 4 months of age and older. Safe use has not been evaluated in dogs with gastrointestinal obstruction, or those that have ingested toxins. Use with caution in dogs with hepatic dysfunction. Pain and vocalization upon injection is a common side e ect. In people, topical exposure may elicit localized allergic skin reactions, and repeated or prolonged exposure may lead to skin sensitization.
See full Prescribing Information.


  1. Ramsey D, Fleck T, Berg T, et al. Cerenia prevents perioperative nausea and vomiting and improves recovery in dogs undergoing routine surgery. Intern J Appl Res Vet Med. 2014;12(3):229-238.
  2. ZMR: Cerenia Quick Poll Survey Results Aggregate July 24, 2017
  3. Kraus B, Cazlan C. Assessment of dog owner concern regarding perioperative nausea and vomiting and willingness to pay for antiemetic treatment. Vet Anaesth Analg. 2O15;42:A58.
  4. ZMR: Emesis360 Survey Results October 16, 2017.
  5. Cerenia (maropitant citrate) Injectable Freedom of Information Summary, supplemental. NADA 141-263. January 11, 2016.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may have di erent labeling in di erent countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2022 Zoetis Services LLC. All rights reserved. CER-00547 R1



We are open Mon–Fri, 8am–8pm ET

zoetis logo

This site is intended for U.S. Animal Healthcare Professionals.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2022 Zoetis Services LLC. All rights reserved.